Carbetocin (Duratocin) Market Report – Research, Industry Analysis Reports and Market Demands

Global Carbetocin (Duratocin) Market Insights, Forecast to 2025

Request for Sample of this report

Buy now

Table of Content

1 Study Coverage

1.1 Carbetocin (Duratocin) Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
- 1.4.1 Global Carbetocin (Duratocin) Market Size Growth Rate by Product
- 1.4.2 Tablets
- 1.4.3 Injection
1.5 Market by End User
- 1.5.1 Global Carbetocin (Duratocin) Market Size Growth Rate by End User
- 1.5.2 Oxytocic
- 1.5.3 Antihemorrhagic
- 1.5.4 Uterotonic
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary

2.1 Global Carbetocin (Duratocin) Market Size
- 2.1.1 Global Carbetocin (Duratocin) Revenue 2014-2025
- 2.1.2 Global Carbetocin (Duratocin) Sales 2014-2025
2.2 Carbetocin (Duratocin) Growth Rate by Regions
- 2.2.1 Global Carbetocin (Duratocin) Sales by Regions
- 2.2.2 Global Carbetocin (Duratocin) Revenue by Regions

3 Breakdown Data by Manufacturers

3.1 Carbetocin (Duratocin) Sales by Manufacturers
- 3.1.1 Carbetocin (Duratocin) Sales by Manufacturers
- 3.1.2 Carbetocin (Duratocin) Sales Market Share by Manufacturers
- 3.1.3 Global Carbetocin (Duratocin) Market Concentration Ratio (CR5 and HHI)
3.2 Carbetocin (Duratocin) Revenue by Manufacturers
- 3.2.1 Carbetocin (Duratocin) Revenue by Manufacturers (2014-2019)
- 3.2.2 Carbetocin (Duratocin) Revenue Share by Manufacturers (2014-2019)
3.3 Carbetocin (Duratocin) Price by Manufacturers
3.4 Carbetocin (Duratocin) Manufacturing Base Distribution, Product Types
- 3.4.1 Carbetocin (Duratocin) Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Carbetocin (Duratocin) Product Type
- 3.4.3 Date of International Manufacturers Enter into Carbetocin (Duratocin) Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

4.1 Global Carbetocin (Duratocin) Sales by Product
4.2 Global Carbetocin (Duratocin) Revenue by Product
4.3 Carbetocin (Duratocin) Price by Product

5 Breakdown Data by End User

5.1 Overview
5.2 Global Carbetocin (Duratocin) Breakdown Data by End User

6 North America

6.1 North America Carbetocin (Duratocin) by Countries
- 6.1.1 North America Carbetocin (Duratocin) Sales by Countries
- 6.1.2 North America Carbetocin (Duratocin) Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
6.2 North America Carbetocin (Duratocin) by Product
6.3 North America Carbetocin (Duratocin) by End User

7 Europe

7.1 Europe Carbetocin (Duratocin) by Countries
- 7.1.1 Europe Carbetocin (Duratocin) Sales by Countries
- 7.1.2 Europe Carbetocin (Duratocin) Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
7.2 Europe Carbetocin (Duratocin) by Product
7.3 Europe Carbetocin (Duratocin) by End User

8 Asia Pacific

8.1 Asia Pacific Carbetocin (Duratocin) by Countries
- 8.1.1 Asia Pacific Carbetocin (Duratocin) Sales by Countries
- 8.1.2 Asia Pacific Carbetocin (Duratocin) Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
8.2 Asia Pacific Carbetocin (Duratocin) by Product
8.3 Asia Pacific Carbetocin (Duratocin) by End User

9 Central & South America

9.1 Central & South America Carbetocin (Duratocin) by Countries
- 9.1.1 Central & South America Carbetocin (Duratocin) Sales by Countries
- 9.1.2 Central & South America Carbetocin (Duratocin) Revenue by Countries
- 9.1.3 Brazil
9.2 Central & South America Carbetocin (Duratocin) by Product
9.3 Central & South America Carbetocin (Duratocin) by End User

10 Middle East and Africa

10.1 Middle East and Africa Carbetocin (Duratocin) by Countries
- 10.1.1 Middle East and Africa Carbetocin (Duratocin) Sales by Countries
- 10.1.2 Middle East and Africa Carbetocin (Duratocin) Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
10.2 Middle East and Africa Carbetocin (Duratocin) by Product
10.3 Middle East and Africa Carbetocin (Duratocin) by End User

11 Company Profiles

12 Future Forecast

12.1 Carbetocin (Duratocin) Market Forecast by Regions
- 12.1.1 Global Carbetocin (Duratocin) Sales Forecast by Regions 2019-2025
- 12.1.2 Global Carbetocin (Duratocin) Revenue Forecast by Regions 2019-2025
12.2 Carbetocin (Duratocin) Market Forecast by Product
- 12.2.1 Global Carbetocin (Duratocin) Sales Forecast by Product 2019-2025
- 12.2.2 Global Carbetocin (Duratocin) Revenue Forecast by Product 2019-2025
12.3 Carbetocin (Duratocin) Market Forecast by End User
12.4 North America Carbetocin (Duratocin) Forecast
12.5 Europe Carbetocin (Duratocin) Forecast
12.6 Asia Pacific Carbetocin (Duratocin) Forecast
12.7 Central & South America Carbetocin (Duratocin) Forecast
12.8 Middle East and Africa Carbetocin (Duratocin) Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

14.1 Value Chain Analysis
14.2 Carbetocin (Duratocin) Customers
14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
16.2 Author Details

Description

The global Carbetocin (Duratocin) market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Carbetocin (Duratocin) market based on company, product type, end user and key regions.

This report studies the global market size of Carbetocin (Duratocin) in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Carbetocin (Duratocin) in these regions.
This research report categorizes the global Carbetocin (Duratocin) market by top players/brands, region, type and end user. This report also studies the global Carbetocin (Duratocin) market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Beacon Pharmaceuticals Limited
Ferring Inc.
Polypeptide Laboraries France
Chemos GmbH & Co. KG
Hangzhou Dayangchem Co. Ltd.
Acinopeptide Co., Ltd.
Bachem AG
Clearsynth Canada INC.
Leap Labchem Co., Ltd
Chemieliva Pharmaceutical Co., Ltd.
Acinopeptide Co., Ltd.
BOC Sciences

Market size by Product
Tablets
Injection
Market size by End User
Oxytocic
Antihemorrhagic
Uterotonic

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Carbetocin (Duratocin) market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Carbetocin (Duratocin) market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Carbetocin (Duratocin) companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Carbetocin (Duratocin) submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Carbetocin (Duratocin) are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Carbetocin (Duratocin) market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.